BNP Paribas Financial Markets’s Argos Therapeutics, Inc. ARGS Stock Holding History

BNP Paribas Financial Markets’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Hold	0	–	-$1	–	4416
2017 Q3	–	Hold	0	–	–	–	4240
2017 Q2	–	Sell	-1	Closed	-$9	–	4260
2017 Q1	$8	Sell	1 -9	-90%	-$570	﹤0.01%	4063
2016 Q4	$985	Sell	10 -36	-78%	-$3.37K	﹤0.01%	4018
2016 Q3	$4.57K	Buy	46 +25	+119%	+$2.61K	﹤0.01%	3402
2016 Q2	$2.59K	Buy	+21	New	+$2.8K	﹤0.01%	3431
2014 Q4	–	Sell	-18	Closed	-$3.67K	–	4174
2014 Q3	$3.67K	Sell	18 -10	-36%	-$1.56K	﹤0.01%	3882
2014 Q2	$4.53K	Buy	+28	New	+$4.63K	﹤0.01%	2637

Other funds holding ARGS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BNP Paribas Financial Markets's ARGS Position: Q4 2017 in Review

BNP Paribas Financial Markets held its Argos Therapeutics, Inc. (ARGS) position steady in Q4 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4416.

BNP Paribas Financial Markets first reported a position in ARGS in Q2 2014 and has held it in 6 quarters since. The position peaked at $4.57K in Q3 2016. 28 funds tracked by Wall St. Rank hold ARGS as of Q4 2017.

BNP Paribas Financial Markets held 0 shares of Argos Therapeutics, Inc. worth $0 as of Q4 2017.
BNP Paribas Financial Markets left its Argos Therapeutics, Inc. share count unchanged in Q4 2017.
Argos Therapeutics, Inc. made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q4 2017, its #4416 holding.
BNP Paribas Financial Markets first reported a position in Argos Therapeutics, Inc. in Q2 2014 and has held it in 6 quarters since.
BNP Paribas Financial Markets's Argos Therapeutics, Inc. position peaked at $4.57K in Q3 2016.
28 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2017.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2017, filed 1 Feb 2018.